185 related articles for article (PubMed ID: 22500984)
1. Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
Hester J; Schiopu A; Nadig SN; Wood KJ
Am J Transplant; 2012 Aug; 12(8):2008-16. PubMed ID: 22500984
[TBL] [Abstract][Full Text] [Related]
2. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.
Nadig SN; Wieckiewicz J; Wu DC; Warnecke G; Zhang W; Luo S; Schiopu A; Taggart DP; Wood KJ
Nat Med; 2010 Jul; 16(7):809-13. PubMed ID: 20473306
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Interleukin-2 Combined With Rapamycin Led to an Expansion of CD4
Hu M; Hawthorne WJ; Nicholson L; Burns H; Qian YW; Liuwantara D; Jimenez Vera E; Chew YV; Williams L; Yi S; Keung K; Watson D; Rogers N; Alexander SI; O'Connell PJ
Diabetes; 2020 Aug; 69(8):1735-1748. PubMed ID: 32381646
[TBL] [Abstract][Full Text] [Related]
4. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients.
Siemeni T; Knöfel AK; Madrahimov N; Sommer W; Avsar M; Salman J; Ius F; Frank N; Büchler G; Jonigk D; Jansson K; Maus U; Tudorache I; Falk CS; Haverich A; Warnecke G
Am J Transplant; 2016 Nov; 16(11):3150-3162. PubMed ID: 27273729
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.
Coenen JJ; Koenen HJ; van Rijssen E; Hilbrands LB; Joosten I
Blood; 2006 Feb; 107(3):1018-23. PubMed ID: 16210336
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts.
Xia G; He J; Leventhal JR
Am J Transplant; 2008 Feb; 8(2):298-306. PubMed ID: 18190656
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.
Wu DC; Hester J; Nadig SN; Zhang W; Trzonkowski P; Gray D; Hughes S; Johnson P; Wood KJ
Transplantation; 2013 Oct; 96(8):707-16. PubMed ID: 23917725
[TBL] [Abstract][Full Text] [Related]
10. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A
Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517
[TBL] [Abstract][Full Text] [Related]
11. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells.
Siemeni T; Knöfel AK; Ius F; Sommer W; Salman J; Böthig D; Falk CS; Tudorache I; Haverich A; Warnecke G
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2528-2537. PubMed ID: 30955963
[TBL] [Abstract][Full Text] [Related]
12. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
[TBL] [Abstract][Full Text] [Related]
13. Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells.
Tresoldi E; Dell'Albani I; Stabilini A; Jofra T; Valle A; Gagliani N; Bondanza A; Roncarolo MG; Battaglia M
Haematologica; 2011 Sep; 96(9):1357-65. PubMed ID: 21565906
[TBL] [Abstract][Full Text] [Related]
14. iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation.
Cheng PP; Liu XC; Ma PF; Gao C; Li JL; Lin YY; Shao W; Han S; Zhao B; Wang LM; Fu JZ; Meng LX; Li Q; Lian QZ; Xia JJ; Qi ZQ
Stem Cells Dev; 2015 Aug; 24(15):1793-804. PubMed ID: 25867817
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation.
Gagliani N; Gregori S; Jofra T; Valle A; Stabilini A; Rothstein DM; Atkinson M; Roncarolo MG; Battaglia M
PLoS One; 2011; 6(12):e28434. PubMed ID: 22174806
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells.
Wang C; Yi T; Qin L; Maldonado RA; von Andrian UH; Kulkarni S; Tellides G; Pober JS
J Clin Invest; 2013 Apr; 123(4):1677-93. PubMed ID: 23478407
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model.
Ogino H; Nakamura K; Iwasa T; Ihara E; Akiho H; Motomura Y; Akahoshi K; Igarashi H; Kato M; Kotoh K; Ito T; Takayanagi R
J Gastroenterol; 2012 Apr; 47(4):366-76. PubMed ID: 22189601
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cells.
Duan W; Yu X; Ma D; Yang B; Li Y; Huang L; Liu L; Chen G; Xu D; Ding Y
Biochem Biophys Res Commun; 2018 Nov; 506(3):619-625. PubMed ID: 30454697
[TBL] [Abstract][Full Text] [Related]
20. Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice.
Pilon CB; Petillon S; Naserian S; Martin GH; Badoual C; Lang P; Azoulay D; Piaggio E; Grimbert P; Cohen JL
Am J Transplant; 2014 Dec; 14(12):2874-82. PubMed ID: 25394722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
